Abstract: The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions.

Abstract: The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions.

Abstract: The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions.

Abstract: The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions.

Abstract: The present invention relates to compositions and methods for enhancement of sexual pleasure and disorders related to sexual pleasure especially in mammalian females. The present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction such as female sexual arousal disorders (FSAD), orgasmic disorders, sexual pain disorders and enhancing female sexual pleasure and satisfaction. The present invention relates to compositions comprising botanical extracts and active agents which are useful to treat or affect any of the aforementioned conditions. The present invention relates to a composition, preferably for topical or local use, which comprises one or more of the following ingredients; including, but not limited to, borage seed oil, Angelica pubescens root and other Angelica species, Coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric triglyceride, caprylic triglyceride, silica and equivalents thereof.

Abstract: The present invention relates to novel mammalian DNA-R proteins and genes that encode such proteins. The invention is directed toward the isolation and characterization of mammalian DNA-R proteins. The invention specifically provides isolated complementary DNA copies of mRNA corresponding to rat and human homologues of a mammalian DNA-R gene. Also provided are recombinant expression constructs capable of expressing the mammalian DNA-R genes of the invention in cultures of transformed prokaryotic and eukaryotic cells, as well as such cultures of transformed cells that synthesize the mammalian catecholamine receptor proteins encoded therein. The invention also provides methods for screening compounds in vitro that are capable of binding to the mammalian DNA-R proteins of the invention, and further characterizing the binding properties of such compounds in comparison with known DNA-R agonists and antagonists. Improved methods of pharmacological screening are provided thereby.

Abstract: The present invention relates to novel mammalian DNA-R proteins and genes that encode such proteins. The invention is directed toward the isolation and characterization of mammalian DNA-R proteins. The invention specifically provides isolated complementary DNA copies of mRNA corresponding to rat and human homologues of a mammalian DNA-R gene. Also provided are recombinant expression constructs capable of expressing the mammalian DNA-R genes of the invention in cultures of transformed prokaryotic and eukaryotic cells, as well as such cultures of transformed cells that synthesize the mammalian catecholamine receptor proteins encoded therein. The invention also provides methods for screening compounds in vitro that are capable of binding to the mammalian DNA-R proteins of the invention, and further characterizing the binding properties of such compounds in comparison with known DNA-R agonists and antagonists. Improved methods of pharmacological screening are provided thereby.

Abstract: The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions.

Abstract: Disclosed is a therapeutic regime for treating patients with rheumatoid arthritis (RA) Supplemental growth hormone is periodically administered to raise insulin-like growth factor 1 (IGF-1) levels, and the IGF-1 levels are monitored until they reach optimal levels and RA symptoms subside.

Abstract: Continuous web-fed rotary tuck and jaw type folding apparatus, typically for high speed periodical, catalogue or newspaper production, is speedily and readily convertible to produce differently page sized and differently folded signatures.

Abstract: A method and circuit for generating an output signal representative of the pumping current required to equalize the oxygen diffusion between the sensing cell and the pumping cell of an oxygen-ion concentration proportional sensor located in the exhaust system of an internal combustion engine. A replication current, which is isolated from but representative of the pumping current, is generated. The replication current is then passed through a load resistance for generating the output signal. The replication current is generated simultaneously with but isolated from the pumping current, thereby eliminating the need for separate amplification of a sensed version of the pumping current.

Abstract: Disclosed is a therapeutic regime for treating patients with fibromyalgia (FM) and other syndromes characterized by non-restorative sleep and musculoskeletal pain. Supplemental growth hormone (GH) is administered and somatomedin-C (SMC) levels monitored until SMC levels reach optimal levels and musculoskeletal pain and fatiguability symptoms subside.

Abstract: The input voltage from a fuel tank level sender is processed by an anti-slosh circuit which has a short time constant during a fast acquire operation and a longer time constant during normal operation. The slew rate of the output voltage provided to a gauge is determined by the clock rate of an up/down counter which is determined by switched resistances and a small valued capacitor. Either analog or digital anti-slosh outputs are provided.

Abstract: A delay timer formed by a sequence of inverters alternating in type, some with single and some with multiple outputs each having an output connected to the input of the next. An output from each of the multiple output inverters is connected to the timer output.

Abstract: A power controller system for providing electrical power to a multiplicity of loads at outputs thereof under direction of a plurality of input controllers operating a corresponding plurality of output energization means with the controllers capable of having different output states in response to differnt system input signals, the controller having selected common components for forcing selected ones of said input controllers to terminate power to corresponding loads. Current sensing means upsetting current balances in bipolar transistors are used to sense beyond-limit currents.

Abstract: A data telemetry system for use with implanted medical devices for transmitting digital and analog data to a remote receiver by enabling different combinations of fixed and variable value current sources according to a telemetry logic code to energize a tank coil and produce a ringing type of variable frequency RF signal.

Abstract: An improved encoder/decoder circuit which utilizes a phase locked loop frequency synthesizer configuration to permit both encoder and decoder operation. In addition, a sampling filter detector is employed to permit monolithic integration of the circuit and minimize sensitivity to vibration. The sampling filter detector has digitally controlled bandwidth which permits rapid response to reverse burst turn-off. In addition, the circuit includes a pulse adder to implement an energy limited reverse burst turn-off mode.

Abstract: An improved differential amplifier includes two Darlington transistor pairs (44-45, 46-47) connected to form a Darlington differential amplifier having complementary sides. Two cross-coupling transistors (50, 52) connect thereto for providing complementary positive feedback of gain less than one between the sides. The cross-coupling transistors significantly improve the differential gain and differential input resistance of the Darlington amplifier.

Abstract: An improved sampling filter detector circuit for sampling input signals of different frequencies and providing a detect signal when the input frequency has a desired predetermined value. The circuit is suitable for use as a tone detector for continuous tone control squelch systems. The sampling filter detector substantially eliminates response to low order harmonics of the desired frequency and provides the ability to program the filter detector bandwidth by digital means without altering passive components thereby permitting reverse burst detection.

Abstract: A system is disclosed for accurately providing a signal or signals indicative of the relatively sharp leading edge and the relatively attenuated trailing edge of a pulse and in particular of a pulse applied by a heart pacemaker to a patient's heart. The system of this invention functions to distinctly detect each of the relatively fast rising leading edge and the relatively slow rising trailing edge, while preventing a premature detection of the trailing upon the attenuated or drooping portion of the pacing pulse therebetween.